This Hims & Hers Move Could Destroy Competitors
Hims Hers (NYSE: HIMS) has had a rough go of it in 2026, but a recent deal with Novo Nordisk (NYSE: NVO) may bring the company's operations back to life. The Wegovy pill is one of the products coming to Hims Hers, and we now know details of what that launch will look like, and it could make this a high-growth stock by the end of 2026. In this video, I explain why this launch is so exciting.
*Stock prices used were end-of-day prices of March 18, 2026. The video was published on March 20, 2026.
Source Fool.com


